A phase I trial of lurbinectedin in combination with cisplatin in patients with advanced solid tumors
{{output}}
Background In vitro/in vivo data showed synergism of cisplatin and lurbinectedin in ovarian cancer cells and grafts. This phase I trial investigated the recommended phase II dose (RD) of cisplatin and lurbinectedin combination, with (Group A) or without aprepi... ...
